Keloid excision and recurrence prophylaxis via intradermal interferon- gamma injections: A pilot study

Laryngoscope

Volumn 106, Issue 12, 1996, Pages 1497-1501

  Broker, Brian J ^b,c   Rosen, David ^c   Amsberry, James ^c   Schmidt, Richard ^c   Sailor, Linda ^a   Pribitkin, Edmund A ^c   Keane, William M ^c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PLACEBO; TRANSFORMING GROWTH FACTOR BETA;

ACNE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; INTRADERMAL DRUG ADMINISTRATION; KELOID; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TREATMENT PLANNING; WOUND HEALING;

EID: 0029807849     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199612000-00010     Document Type: Article

References (16)

1. Stucker FJ, Shaw GY. Keloids and hypertrophic scars. In: Papel ID, Nachlas NE, eds. Facial Plastic and Reconstructive Surgery. St. Louis: Mosby - Year Book; 1992.
2. Jiminez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest. 1984;74:1112-1116.
3. Golgring MB, Sandell LJ, Stephenson ML, et al. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. J Biol Chem. 1986;261:9049-9055.
4. Duncan MR, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med. 1985;162:516-527.
5. Stephenson ML, Krane SM, Amento EP, et al. Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs. FEBS Lett. 1985;180:43-50.
6. Larrabee WF, East CA, Jaffe HS, et al. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg. 1990;116:1159-1162.
7. Granstein RD, Rook A, Flotte TJ, et al. A controlled trial of intralesional recombinant interferon gamma in the treatment of keloidal scarring. Arch Dermatol. 1990;126:1295-1302.
8. International Chronic Granulomatous Disease Cooperative Study Group (ICGDCSG): A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New Engl J Med. 1991;324:509-516.
9. Todd PA, Goa KL. Interferon gamma-1B: a review of its pharmacology and theraputic potential in chronic granulomatous disease. Drugs. 1992;43:11-122.
10. Steinmann GG, Rosenkaimer F, Leitz G. Clinical experiences with interferon alpha and interferon gamma. Int Rev Exp Pathol. 1993;34B:193-207.
11. Stucker FJ, Hoasjoe DK, Aarstad RF. Facial scars and keloids. In: Gates GA, ed. Current Therapy in Otolaryngology - Head and Neck Surgery. 5th ed. St. Louis: Mosby - Year Book; 1994:113-118.
12. Granstein RD, Deak MR, Jacques SL, et al. The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model. J Invest Dermatol. 1989;93:18-27.
13. Giri FN, Hyde DM, Marafino BJ. Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. Biochem Med Metabol Biol. 1986;36:194-197.
14. Granstein RD, Murphy GF, Margolis RJ, et al. Gamma interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest. 1987;79:1254-1258.
15. Kahan A, Amor B, Menkes CJ, et al. Recombinant interferon gamma in the treatment of systemic sclerosis. Am J Med. 1989;87:273-277.
16. Kikuchi K, Kadono T, Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology. 1995;190:4-8.